Browse Tasks

Select category

Select category

Select category

Select category

Select Task

Select Task

Select Task

Select Task

Select Tasks

Select Industry

Customer Onboarding Pre-triage

Investment Portfolio Analysis

Compliance and Regulatory Check

Fraud Detection

Transaction Categorisation

Financial Product Recommendation

News Article Summary

Financial Analysis

Investment Portfolio Analysis

This agentic task evaluates and optimises investment portfolios - essential for portfolio management agents. The task specification outlines how to:

  • Analyse portfolio composition and performance metrics

  • Calculate risk exposure and diversification levels

  • Identify strategic rebalancing opportunities

  • Generate evidence-based investment recommendations

  • Produce structured portfolio analysis with performance projections


As a modular agentic task, it integrates with portfolio management systems and market data platforms, enabling AI agents to execute systematic portfolio optimisation within existing wealth management workflows. The task specification includes frameworks for performance analysis, risk assessment, and investment optimisation, adaptable across various investment strategies and client profiles.

Example outputs:

"response": {
    "risk_assessment": "The portfolio exhibits moderate risk with a historical volatility of 12% annually. The Value at Risk (VaR) is calculated at 5% for a 95% confidence interval and 8% for a 99% confidence interval. The maximum drawdown observed was 15% with a recovery period of 8 months. The beta against the S&P 500 is 1.1, indicating slightly higher market sensitivity. Stress testing shows resilience in moderate downturn scenarios but vulnerability in severe market contractions.",
    "portfolio_summary": "The portfolio is composed of 60% equities, 30% fixed income, and 10% alternatives. Sector-wise, it is heavily weighted in technology (25%) and healthcare (20%), with moderate exposure to financials (15%) and consumer goods (10%). Geographic exposure is 70% developed markets and 30% emerging markets. The largest individual position is 8% of the total portfolio, indicating moderate concentration risk. Currency exposure is primarily in USD (80%), with minor exposures to EUR and JPY.",
    "performance_analysis": "The portfolio has delivered a 1-year trailing return of 10%, a 3-year annualized return of 8%, and a 5-year annualized return of 9%. Compared to the S&P 500, which returned 12% over the past year, the portfolio underperformed slightly. The Sharpe ratio is 0.8, indicating a reasonable risk-adjusted return.",
    "projected_performance": "Based on current market trends and portfolio composition, the projected 1-year return is estimated at 7%, with a 3-year annualized projection of 8%. The portfolio is expected to benefit from continued growth in technology and healthcare sectors, although potential interest rate hikes could impact fixed income returns.",
    "investment_opportunities": "Consider increasing exposure to renewable energy and technology sectors, which are expected to outperform in the coming years. Emerging markets offer growth potential, particularly in Asia. Additionally, exploring high-yield bonds could enhance income generation.",
    "rebalancing_recommendations": [
      "Reduce technology sector exposure from 25% to 20% to mitigate concentration risk.",
      "Increase fixed income allocation from 30% to 35% to enhance portfolio stability.",
      "Diversify geographic exposure by increasing emerging markets allocation from 30% to 35%.",
      "Reallocate 5% from USD to EUR to hedge against currency risk."
    ],
    "requires_immediate_attention": "No"